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ABSTRACT 
 
Gene Expression Profiling of 3T3-L1 Adipocytes Expressing the 
Mitochondrial Uncoupling Protein 1 (UCP1) (April 2006) 
 
Fatih S. Senocak 
Department of Biology 
Texas A&M University 
 
Research Advisor: Dr. Arul Jayaraman 
Department of Chemical Engineering 
 
 
 
During the past 20 years, there has been a significant increase in the 
number of individuals developing type II diabetes mellitus (T2DM).  
Evidence from several studies indicates that obesity and weight gain 
(increase in white adipose tissue) are associated with an increased risk of 
developing diabetes.  Current treatments to combat this epidemic involve the 
reduction in white adipose tissue (WAT).  Previously we proposed that the 
forced expression of uncoupling protein 1 (UCP1), normally part of the 
thermogenic mechanisms found in brown adipose tissue (BAT), can be used 
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to reduce accumulation of triglycerides in white adipocytes, and thereby 
regulate body fat mass.  The aim of this study was to determine the effects of 
forced UCP1 expression on global changes in energy metabolism in white 
adipocytes. Specifically, we used DNA microarrays to characterize the 
changes in white adipocyte gene expression upon UCP1 expression and 
determine the extent to which UCP1 expressing white adipocytes emulate 
brown adipocytes. Murine 3T3-L1 preadipocytes, either expressing UCP1 or 
control (i.e., no UCP1) were cultured to confluence. On day 2 post confluence, 
the preadipocytes were induced to differentiate using a standard adipogenic 
cocktail consisting of insulin, isobutylmetyhylxanthine (IBMX), and 
dexamethasone (DEX).  At 10 days post-isolation, total RNA was isolated 
and the transcript levels profiled using the Codelink microarray system 
(Agilent, CA).  
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CHAPTER I 
INTRODUCTION1
 During the last 20 years, obesity has risen significantly in the United 
States. (1). Based on the current statistics, it is believed that 30% of 
Americans are obese and an additional 35% of Americans are overweight 
making 65% of the U.S. population carrying excess weight.  In addition, it is 
not only the adults that are carrying excess weight but the numbers for 
obese children and teens between the ages of 6-15 have tripled within the 
same time period.  Because of this growing epidemic, the demand for 
treatment options has become increasingly necessary. 
 Obesity is defined as a chronic condition that develops due to excess 
accumulation of fats in adipose tissue and skeletal muscle.  It raises the risk 
for many diseases ranging from type II diabetes, hypertension, coronary 
heart disease, and cancer.  Currently, there are only limited methods for 
treating obesity.  Majority of the treatments involve diet and lifestyle 
modification. At this time, only two FDA approved drugs (siburtramine and 
                                                 
1 This thesis follows the style and format of The Journal of Biological Chemistry.  
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orlisat) are available. (2) However, these drugs have had little success as 
there are numerous side effects.   
Within the last few years, the view of adipose tissue has changed from 
that of a “mere energy store or provider of thermal and mechanical 
insulation”. (3)  Current research has shown adipose tissue to have 
important endocrine functions that are vital for the maintenance of the 
body’s homeostatis.   Several of the hormones and signaling factors secreted 
by adipose tissue include Leptin, Lipoprotein lipase and several 
inflammatory cytokines. These newly discovered endocrine functions of 
adipose tissue now have led researchers to classify obesity as a state of 
chronic inflammation due to the observed elevated plasma levels of 
inflammatory markers such as interleukin (IL)-6, Tumor necrosis factor 
(TNF) or C-reactive protein (CRP) (4).   
Besides its endocrine functions, WAT also contains anabolic and 
catabolic reactions as part of its metabolic functions.   Lipogenesis uses 
Acetyl-Coenzyme A (CoA) subunits to synthesize fatty acids. In turn, 
triacylglycerides are synthesized by esterification of the fatty acids to 
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glycerol-3-phosphate. β-oxidation, the opposing catabolic reaction to 
lipogenesis, breaks down triacylglycerides into Acetyl-CoA units for the cell 
to use as fuel in the mitochondria. 
It has been demonstrated that two types of adipose tissues exist: 
white adipose tissue (WAT), which stores triglycerides, and brown adipose 
tissue (BAT) which is specialized for adaptive non-shivering thermogenesis. 
(5)  BAT is only found in newborns and children and begins to disappear as 
the individual grows and only WAT is found in adult humans. Therefore, 
understanding the biology of WAT is important for developing therapeutic 
strategies for obesity and related complications.  
In eukaryotic cells, mitochondria are considered to be the “powerhouse 
of the cell” due to their ability to generate the majority to the ATP needed for 
the cell to survive.  Mitochondria, a bilipid organelle, achieve this through a 
process referred to as oxidative phosphorylation.  Cellular respiration, the 
process of oxidizing different molecules to generate ATP, occurs in the 
mitochondria.  Mitochondria contain an inner membrane (cristae) and an 
outer membrane.  The inner membrane contains five integral proteins, 
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Complex I (NADH dehydrogenase), Complex II (Succinate Dehydrogenase), 
Complex III (Cytochrome C reductase), Complex IV (Cytochrome C oxidase) 
and Complex V (F1-F0 ATP Synthase).  Using the cofactors NADH and 
FADH2, the complexes pump protons into intermembrane space of the 
mitochondria to create a proton gradient.  In order to generate ATP, these 
protons flow through the F1-F0 ATP synthase. 
In BAT, UCP1 is believed to integrate itself into the mitochondrial 
membrane causing the hydrogen ions to leak prematurely.  The loss of the 
proton gradient generates heat and reduces ATP synthesis.  Because of this, 
the cell looks to other metabolic pathways to makeup for the net loss in ATP 
production.  This function for UCP1 makes it a promising candidate for WAT 
reduction for obesity treatment. 
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CHAPTER II 
PROBLEM  
Hypothesis 
Forced UCP1 expression in white adipocytes will alter the cells 
expression profile such that it will emulate the thermogenic phenotype of 
brown adipocytes.  
 
Specific Aim1 
To determine the effects of forced UCP1 expression on global changes 
in energy metabolism in white adipocytes. Specifically, to use DNA 
microarrays to characterize the changes in white adipocyte gene expression 
upon UCP1 expression and determine the extent to which UCP1 expressing 
white adipocytes emulate brown adipocytes. 
 
Specific Aim2 
To clone Uncoupling Protein 2 plasmid construct for future studies of 
uncoupling protein biochemistry in white adipocytes.  
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Problem Summary 
The purpose of this study is to characterize the metabolic pathways 
altered in white adipocytes due to the forced expression of UCP1. 
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CHAPTER III 
METHODS 
Cell Culture 
 Previously transfected murine 3T3-L1 preadipocytes with pRevTre 
and pRevTre-UCP1 plasmids will be cultured in Dulbecco's Modified Eagle 
Medium (DMEM) purchased from Invitrogen-Gibco (Carlsbad, California). 
DMEM will contain will be supplemented with CS (10 % v/v), penicillin (200 
u/ml) and streptomycin (200 µg/ml). Cells will be maintained in an incubator 
at 37 °C, with 10% Carbon Dioxide in a fully humidified atmosphere.  During 
this period, medium was replenished every other day.  On day 2 post-
confluence, the cells were induced to differentiate in an adipocytes medium 
(DMEM with 10%FBS and penicillin/streptomycin) supplemented with a 
standard adipogenic medium cocktail consisting of 1ug/ml insulin, 0.5 mM 
isobutylmethylxanthine (IBMX) and 1µM dexamethasone (DEX).  After 48 
hrs, the first induction medium was replaced with a second induction 
medium consisting of the basal adipocytes medium supplemented with only 
insulin.  After another 40 hrs, the second induction medium was replaced 
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with the basal adipocytes medium.  Medium was replenished every other day 
through day 10 post induction.  
 
RNA Extraction 
 At 10 days post-isolation, total RNA was isolated using the RNeasy Mini Kit 
(Qiagen, CA) and the transcript levels profiled using the Codelink microarray system 
(Agilent, CA).  
 
Bioinformatic Analysis of Microarray Data 
 Triplicate samples were used for cell type and one array was used for 
each sample.  The raw data was initially was filtered by selecting only those 
genes that had a “G(ood)” quality flag.  Afterwards a T-test was performed 
(p<0.05) to determine the significant change in the expression levels between 
control and UCP1 adipocytes.  Only those genes that passed the G(ood) 
quality flag and the T-Test was chosen for further analysis. 
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Construction of RevTRE-UCP2 Vector 
 
 The pRevTET-Off, pRevTRE vectors were purchased from BD 
Biosciences (Mountain View, CA). Plasmid pCMV-Sport6-UCP2 containing 
the mus musculus full length cDNA for UCP2 was purchased from 
Invitrogen (Carlsbad, CA). It was digested with Sal1 and Xba1 to remove the 
UCP2 gene from the plasmid. pSP72, a cloning vector was purchased from 
Promega (Madison, WI). It was digested with Sal1 and Xba1 and then 
ligated to the UCP2 gene cut from pCMV-Sport6-UCP2. pSP72 was then  
digested with Sal1 and Cla1 to remove UCP2 which was further ligated into 
pRevTRE, digested with the same set of restriction enzymes.  
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CHAPTER IV 
RESULTS 
 To identify the effects of UCP1 expression on metabolic functions of white 
 
adipocytes, all those genes coding for enzymes in a metabolic processes were examined. 
 
 
 
Table 1: Metabolic pathway gene expression changes 
 
Glycolysis Down regulated 
Glycerogenesis Up regulated  
Lipid catabolism Down regulated 
Lipid biosynthesis Down regulated 
Oxidative phosphorylation Down regulated 
TCA cycle Down regulated 
 
 
 
As expected the highest increase in expression level occurred for the UCP1 
gene, an 8 fold increase in the adipocytes expressing UCP1 when compared 
to control adipocytes.  Moreover, the data revealed that all the genes 
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encoding for enzymes within the glycolytic, TCA cycle, fatty acid oxidative, 
oxidative phosphorylation, and mitochondrial biogenesis pathways had 
decreased expression in UCP1 adipocytes as compared to control adipocytes.  
For example, hexokinase: the first reaction of glycolysis, its expression level 
was 22% less in UCP1 expressing cells than control.  Phosphofructokinase, 
the first committed step in glycolysis, its expression level was 28% less.  
Citrate Synthase, the first step in the TCA cycle, is expression was down 29 
% in UCP1 expressing cells as compared to control.  Also, NADH 
dehydrogenase, complex I of the electron transport chain, had its expression 
level decreased by 20% when comparing the two cell types. 
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CHAPTER V 
CONCLUSIONS 
Examination of the data reveals all of the major metabolic pathways to be 
down regulated with the expression of UCP1 within the cell.  One possible 
explanation for this could be that because of the uncoupling of the oxidative 
phosphorylation pathway, the cell enters a state of ATP depletion and shuts 
down the mechanisms necessary for transcription.  Furthermore, the review 
of the expression levels of ubiqutin: an enzyme, whose function is to degrade 
other proteins, shows a decrease as well.  This down regulation would in 
turn lead to having the cellular enzymes including the ones involved in 
metabolism function for longer periods of time within the cell.  Therefore, the 
cell can still maintain necessary functions without having to make more of 
the enzymes. 
 
 
 
 
 
 13
REFERENCES 
1. Bray, G.A., and Greenway, F.L. (1999) Endocr. Rev. 20, 805-875 
 
2. Dullo, A.G, Seydoux, J., and Jacques J. (2004) Physioloy & Behavior 
83, 587-602 
3. Nicholls, D. G., and Locke, R. M. (1984) Physiol. Rev. 64, 1-64 
4.  Rousset, S., Alves-Guerra M.C, Mozo J., Miroux B., Cassard-Doulcier 
A.M., Bouillaud F., and Ricquier D. (2004) Diabetes 53 pp. S130–S135 
5.  Trayhurn, P. (2005) Acta Physiol Scand. 184, 285-93 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 14
APPENDIX 
 
 
Glycolysis     
 T-test UCP1/control 
Hexokinase 0.032226 0.780519536 
phosphofructokinase 0.027045 0.724710434 
fructobisphosphate aldolase 0.003124 0.546672248 
triosephosphate isomerase 0.048193 0.38862309 
Glyceraldehyde 3 phosphate dehydrogenase 0.025625 0.487525133 
phosphoglycerate kinase 0.013619 0.500681065 
pyruvate kinase 0.001477 1.183126047 
Glycerogenesis     
PEP carboxykinase 0.018451 1.297985551 
glucose 6 phosphatase 0.002062 1.725366205 
Glycogen Metabolism     
glycogen phosphorylase 0.012372 0.688879579 
glycogen synthase 0.001255 0.540651739 
branching enzyme 0.010224 0.356628968 
phosphoglucomutase 0.041361 0.759299316 
Citric acid cycle     
citrate synthase 0.042259 0.716523987 
isocitrate dehydrogenase 0.00989 0.723318154 
succinate dehydrogenase 0.040454 0.793064378 
fumarase 0.029361 0.716030736 
malate dehydrogenase 0.044173 0.788311967 
pyruvate dehydrogenase 0.034541 0.805219592 
Oxidative Phosphorylation   
ATP synthase 0.032525 0.531069806 
ATP synthase 0.019455 0.711261065 
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ATP synthase 0.011162 0.745276908 
ATP synthase 0.042624 0.759738713 
NADH dehydrogenase 0.009978 0.736400743 
NADH dehydrogenase 0.028682 0.801751834 
NADH dehydrogenase 0.013745 0.725320154 
NADH dehydrogenase 0.006624 0.735908631 
NADH dehydrogenase 0.009424 0.798949461 
NADH dehydrogenase 0.020777 0.72122224 
succinate dehydrogenase 0.040454 0.793064378 
coenzyme Q-cytochrome c oxidoreductase 0.035466 0.735586389 
coenzyme Q-cytochrome c oxidoreductase 0.015216 0.739190483 
cytochrome c oxidase 0.00014 0.348234763 
cytochrome c oxidase 0.022744 0.710150452 
Aminoacid Metabolism     
asparagine synthetase 0.009692 0.771154816 
Lipid Catabolism     
Carnitine acytransferase II 0.005432 0.635574565 
Acyl coa dehydrogenase 0.026676 0.691482326 
enoyl coa hydratase 0.000924 0.797711393 
beta hydroxyacyl dehydrogenase 0.033687 0.68291956 
thiolase 0.03709 0.7940302 
propinoyl coa carboxylase 0.012611 0.684424659 
Lipid Biosynthesis     
fatty acid synthase 0.023002 0.831595905 
Uncoupling Proteins      
uncoupling protein 1 0.017496 8.056634747 
uncoupling protein 3 0.027442 0.718022479 
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Cytochrome P40     
Cytochrome P40 0.027379 0.712114297 
Cytochrome P40 0.033757 4.89964546 
Cytochrome P40 0.000184 1.562875437 
Cytochrome P40 0.03457 1.536311498 
Cytochrome P40 0.011692 3.619635454 
Cytochrome P40 0.032724 0.787030393 
Cytochrome P40 0.033825 2.256590601 
Cytochrome P40 0.009485 1.901329882 
Cytochrome P40 0.000431 0.63301888 
 
 17
 
CONTACT INFORMATION 
 
Name:                 Fatih Senocak 
 
Address:              Department of Chemical Engineering,  
                             Texas A&M University 
                             3122 TAMU College Station, Texas, 77843-3122, USA 
 
E-mail address:  fsenocak@ neo.tamu.edu 
 
Education :         B.S. Biology, 2006 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
